DOI:
Keywords:
Cancer, plumbago zeylanica
Abstract
Cancer is a malignant disease that is characterized by rapid and uncontrolled formation of abnormal cells which may mass together to form a growth or tumour, or proliferate throughout the body. Next to heart disease cancer is a major killer of mankind. Present study aims at a preliminary phytochemical screening and anticancer evaluation of plumbago zeylanica Linn against Ehrlich Ascites Carcinoma in animal model. Results indicates that ethanolic extract of plumbago zeylanica Linn possess significant anticancer activity and also reduce elevated level of lipid peroxidation due to higher content of terpenoids and flavonoids. Thus ethanolic extract of plumbago zeylanica Linn could have vast therapeutic application against cancer.
Downloads
Metrics
Downloads
- PDF
Published
How to Cite
Issue
Section
License
Copyright (c) 2010 International Journal of Biomedical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.
